Theseus Pharmaceuticals Inc
NASDAQ:THRX
Theseus Pharmaceuticals Inc
Depreciation & Amortization
Theseus Pharmaceuticals Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theseus Pharmaceuticals Inc
NASDAQ:THRX
|
Depreciation & Amortization
$50k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Depreciation & Amortization
$7.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Depreciation & Amortization
$9.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
72%
|
CAGR 10-Years
31%
|
|
Pfizer Inc
NYSE:PFE
|
Depreciation & Amortization
$6.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
Merck & Co Inc
NYSE:MRK
|
Depreciation & Amortization
$3.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-6%
|
|
Eli Lilly and Co
NYSE:LLY
|
Depreciation & Amortization
$1.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Theseus Pharmaceuticals Inc's Depreciation & Amortization?
Depreciation & Amortization
50k
USD
Based on the financial report for Dec 31, 2022, Theseus Pharmaceuticals Inc's Depreciation & Amortization amounts to 50k USD.